{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:47:55Z","timestamp":1791244075414,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2851,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemistry &amp; Biology"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.chembiol.2005.09.007","type":"journal-article","created":{"date-parts":[[2005,11,19]],"date-time":"2005-11-19T07:15:24Z","timestamp":1132384524000},"page":"1235-1244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":164,"title":["Gaucher Disease-Associated Glucocerebrosidases Show Mutation-Dependent Chemical Chaperoning Profiles"],"prefix":"10.1016","volume":"12","author":[{"given":"Anu R.","family":"Sawkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara L.","family":"Adamski-Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chieh","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Huey","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Beutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Peter","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery W.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2005.09.007_bib1","first-page":"377","article-title":"Gaucher disease. Enzymology, genetics, and treatment","volume":"21","author":"Grabowski","year":"1993","journal-title":"Adv. Hum. Genet."},{"key":"10.1016\/j.chembiol.2005.09.007_bib2","first-page":"85","article-title":"Gaucher disease: gene frequencies in the Ashkenazi Jewish population","volume":"52","author":"Beutler","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.chembiol.2005.09.007_bib3","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00018-002-8458-y","article-title":"Gaucher disease: perspectives on a prototype lysosomal disease","volume":"59","author":"Zhao","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.chembiol.2005.09.007_bib4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1025902113005","article-title":"The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement","volume":"26","author":"Cox","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.chembiol.2005.09.007_bib5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.chembiol.2005.09.007_bib6","first-page":"83","article-title":"Gaucher disease, enzyme replacement therapy, and the Patient Assistance Program","volume":"19","author":"Goldwater","year":"1996","journal-title":"J. Intraven. Nurs."},{"key":"10.1016\/j.chembiol.2005.09.007_bib7","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.chembiol.2005.09.007_bib8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/B:BOLI.0000045756.54006.17","article-title":"Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease","volume":"27","author":"Elstein","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.chembiol.2005.09.007_bib9","doi-asserted-by":"crossref","first-page":"13478","DOI":"10.1074\/jbc.M308523200","article-title":"Pharmacological enhancement of \u03b2-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff patients","volume":"279","author":"Tropak","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2005.09.007_bib10","doi-asserted-by":"crossref","first-page":"17921","DOI":"10.1016\/S0021-9258(18)38251-6","article-title":"Two mutations produce intron insertion in mRNA and elongated \u03b2-subunit of human \u03b2-hexosaminidase","volume":"265","author":"Dlott","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2005.09.007_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000112332","article-title":"Partial enzyme deficiencies: residual activities and the development of neurological disorders","volume":"6","author":"Conzelmann","year":"1984","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.chembiol.2005.09.007_bib12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1023\/B:BOLI.0000042959.44318.7c","article-title":"Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease","volume":"27","author":"Schueler","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.chembiol.2005.09.007_bib13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF03401556","article-title":"Failure of alglucerase infused into Gaucher disease patients to localize in marrow macrophages","volume":"1","author":"Beutler","year":"1995","journal-title":"Mol. Med."},{"key":"10.1016\/j.chembiol.2005.09.007_bib14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1600-0854.2004.00232.x","article-title":"Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease","volume":"5","author":"Ulloa-Aguirre","year":"2004","journal-title":"Traffic"},{"key":"10.1016\/j.chembiol.2005.09.007_bib15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.coph.2004.08.001","article-title":"Pharmacological chaperone action on G-protein-coupled receptors","volume":"4","author":"Bernier","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.chembiol.2005.09.007_bib16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/4801","article-title":"Accelerated transport and maturation of lysosomal \u03b1-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor","volume":"5","author":"Fan","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2005.09.007_bib17","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1073\/pnas.2536657100","article-title":"Chemical chaperone therapy for brain pathology in GM1-gangliosidosis","volume":"100","author":"Matsuda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2005.09.007_bib18","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S \u03b2-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2005.09.007_bib19","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1172\/JCI119437","article-title":"Identification and expression of acid \u03b2-glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher disease in non-Jewish patients","volume":"99","author":"Grace","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.chembiol.2005.09.007_bib20","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/S0021-9258(17)42166-1","article-title":"Analysis of human acid \u03b2-glucosidase by site-directed mutagenesis and heterologous expression","volume":"269","author":"Grace","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2005.09.007_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1098-1004(200002)15:2<181::AID-HUMU7>3.0.CO;2-S","article-title":"Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease","volume":"15","author":"Stone","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.chembiol.2005.09.007_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0167-4838(87)90128-2","article-title":"Human acid \u03b2-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites","volume":"915","author":"Osiecki-Newman","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.chembiol.2005.09.007_bib23","doi-asserted-by":"crossref","first-page":"26522","DOI":"10.1074\/jbc.273.41.26522","article-title":"Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal glucosylceramidase","volume":"273","author":"Overkleeft","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2005.09.007_bib24","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1042\/BJ20031824","article-title":"Cellular effects of deoxynojirimycin analogues: inhibition of N-linked oligosaccharide processing and generation of free glucosylated oligosaccharides","volume":"381","author":"Mellor","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.chembiol.2005.09.007_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00731489","article-title":"Treatment of Gaucher disease with an enzyme inhibitor","volume":"13","author":"Radin","year":"1996","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.chembiol.2005.09.007_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/ncmn.1993.1048","article-title":"Use of an inhibitor of glucosylceramide synthesis, D-1-phenyl-2-decanoylamino-3-morpholino-1-propanol","volume":"3","author":"Radin","year":"1993","journal-title":"NeuroProtocols"},{"key":"10.1016\/j.chembiol.2005.09.007_bib27","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1021\/ja973443k","article-title":"1-N-imino sugars: potent and selective inhibitors of \u03b2-glycosidases","volume":"120","author":"Ichikawa","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2005.09.007_bib28","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/jo00111a007","article-title":"Synthesis and evaluation of homoaza sugars as glycosidase inhibitors","volume":"60","author":"Wong","year":"1995","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.chembiol.2005.09.007_bib29","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1172\/JCI5168","article-title":"Non-pseudogene-derived complex acid \u03b2-glucosidase mutations causing mild type 1 and severe type 2 gaucher disease","volume":"103","author":"Grace","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.chembiol.2005.09.007_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1021\/bi035918s","article-title":"Destabilizing mutations promote membrane protein misfolding","volume":"43","author":"Nagy","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2005.09.007_bib31","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/sj.embor.embor873","article-title":"X-ray structure of human acid-\u03b2-glucosidase, the defective enzyme in Gaucher disease","volume":"4","author":"Dvir","year":"2003","journal-title":"EMBO Rep."},{"key":"10.1016\/j.chembiol.2005.09.007_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<407::AID-PATH377>3.0.CO;2-Z","article-title":"Intracellular transport of acid \u03b2-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation)","volume":"188","author":"Zimmer","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.chembiol.2005.09.007_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbadis.2004.03.007","article-title":"N-Octyl-\u03b2-valienamine up-regulates activity of F213I mutant \u03b2-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease","volume":"1689","author":"Lin","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.chembiol.2005.09.007_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0009-8981(81)90384-3","article-title":"Differential assay for lysosomal \u03b1-galactosidases in human tissues and its application to Fabry's disease","volume":"112","author":"Mayes","year":"1981","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.chembiol.2005.09.007_bib35","first-page":"132","article-title":"Biochemical, immunological, and cell genetic studies in glycogenosis type II","volume":"30","author":"Reuser","year":"1978","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.chembiol.2005.09.007_bib36","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1021\/jo040254t","article-title":"RCM-based synthesis of a variety of \u03b2-C-glycosides and their in vitro anti-solid tumor activity","volume":"70","author":"Postema","year":"2005","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.chembiol.2005.09.007_bib37","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1016\/S0040-4020(97)00273-1","article-title":"Synthesis of stable analogs of glyceroglycolipids","volume":"53","author":"Cipolla","year":"1997","journal-title":"Tetrahedron"},{"key":"10.1016\/j.chembiol.2005.09.007_bib38","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1021\/jo0255227","article-title":"Stereochemistry in the synthesis and reaction of exo-glycals","volume":"67","author":"Yang","year":"2002","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.chembiol.2005.09.007_bib39","doi-asserted-by":"crossref","first-page":"7946","DOI":"10.1021\/ja961230+","article-title":"Complete relative stereochemistry of maitotoxin","volume":"118","author":"Zheng","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2005.09.007_bib40","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1016\/S0040-4039(00)94019-X","article-title":"Synthesis and conversions of C-(alkyn-1-yl)-\u03b2-D-glucopyranosides","volume":"24","author":"Lancelin","year":"1983","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.chembiol.2005.09.007_bib41","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1021\/jo960362i","article-title":"Chemical synthesis of \u03b2-homonojirimycin, of its N-butyl derivative, and of \u2018methyl homoazacellobioside\u2019","volume":"61","author":"Saavedra","year":"1996","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.chembiol.2005.09.007_bib42","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/jo00002a009","article-title":"Conversion of D-glucose to L-glucose: oxidative decarboxylation of \u03b1-oxycarboxylic acids via their diacyl peroxides","volume":"56","author":"Shiozaki","year":"1991","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.chembiol.2005.09.007_bib43","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1055\/s-1999-3430","article-title":"Synthesis of 1-deoxynojirimycin and N-butyl-1-deoxynojirimycin","author":"Matos","year":"1999","journal-title":"Synthesis (Mass.)"},{"key":"10.1016\/j.chembiol.2005.09.007_bib44","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1021\/jo00090a040","article-title":"Expeditious synthesis of aza sugars by the double reductive amination of dicarbonyl sugars","volume":"59","author":"Baxter","year":"1994","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.chembiol.2005.09.007_bib45","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1016\/S0040-4039(00)97169-7","article-title":"Pyrrolidine and piperidine amino sugars from dicarbonyl sugars in one step. Concise synthesis of 1-deoxynojirimycin","volume":"31","author":"Reitz","year":"1990","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.chembiol.2005.09.007_bib46","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1002\/1521-3765(20010903)7:17<3744::AID-CHEM3744>3.0.CO;2-3","article-title":"Efficient synthesis of isofagomine and noeuromycin","volume":"7","author":"Andersch","year":"2001","journal-title":"Chemistry"}],"container-title":["Chemistry &amp; Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074552105002978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074552105002978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T07:07:15Z","timestamp":1761030435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074552105002978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S1074552105002978"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2005.09.007","relation":{},"ISSN":["1074-5521"],"issn-type":[{"value":"1074-5521","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gaucher Disease-Associated Glucocerebrosidases Show Mutation-Dependent Chemical Chaperoning Profiles","name":"articletitle","label":"Article Title"},{"value":"Chemistry & Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2005.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}